欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2004, Vol. 9 ›› Issue (12): 1428-1431.

• 研究原著 • 上一篇    下一篇

氟西汀对抑郁症患者精力异常的临床疗效评价

徐松泉, 何旭东, 潘大津, 应益飞, 朱桂东, 王静   

  1. 丽水市第二人民医院精神科, 丽水 323000, 浙江
  • 收稿日期:2004-05-28 修回日期:2004-11-10 出版日期:2004-12-26 发布日期:2020-11-19
  • 通讯作者: 徐松泉, 男, 学士, 副主任医师, 研究方向:情感性精神障碍的诊断与治疗。Tel:0578-2152145 E-mail:ls21xsq@sina.com

Effects of fluoxetine on changes of energy in patients with depression

XU Song-Quan, HE Xu-Dong, PAN Da-Jin, YING Yi-Fei, ZHU Gui-Dong, WANG Jing   

  1. Department of Psychiatry, the Second People's Hospital of Lishui City, Lishui 323000, Zhejiang, China
  • Received:2004-05-28 Revised:2004-11-10 Online:2004-12-26 Published:2020-11-19

摘要: 目的: 为了研究氟西汀是否能有效缓解与抑郁相关的精力异常。方法: 对55 例抑郁症患者进行对照观察, 氟西汀组29 例, 予以氟西汀20 mg, po,qd;阿米替林组26 例, 予以阿米替林75 mg, po, bid;6 周为一疗程。以HAMD 迟滞因子评分为依据, 将患者按基线评分水平划分为低迟滞亚组(HAMD 评分<8) 和高迟滞亚组(HAMD 评分≥8) 。采用HAMD 迟滞因子评分(第1 项:情绪低落、第7 项:工作和活动、第8 项:迟滞、第14 项:生殖器症状、第13项:躯体症状/一般状况) 以及SCL-58 中有关精力项目(第14 项:感觉精力不足、第32 项:感觉对事物没有兴趣、第55 项:专注于自己所遇到的困难) 来衡量精力的改变。结果: 2 组治疗后6 周, HAMD 总分、迟滞因子个条目以及SCL-58 中有关精力项目评分均显著下降, 而氟西汀组下降较阿米替林组更为明显,且在治疗1、2 周末即有显著性差异(P <0.05) 。氟西汀组中高迟滞与低迟滞2 亚组疗效相当(P>0.05), 而阿米替林组中高迟滞亚组疗效较低迟滞亚组差(P <0.05);与阿米替林组相比, 高迟滞亚组接受氟西汀治疗效果更佳(P <0.05) 。结论: 氟西汀能早期有效改善抑郁症的精力症状, 提示临床上对HAMD 迟滞因子分高的病人较阿米替林等具明显镇静作用的药物更为适合。

关键词: 临床试验, 氟西汀, 阿米替林, 抑郁症, 精力改变

Abstract: AIM: To investigate the effects of fluoxetine on the changes of depression-related disturbances in energy.METHODS: 55 patients with depression were randomly assigned to two groups:fluoxetine group (n=29) treated with 20 mg·d-1 fluoxetine, po, qd, and amitriptyline group (n=26) treated with 150 mg·d-1 amitriptyline, po, bid.Two groups were observed for 6 weeks.According to the Hamilton Rating Scale for Depression (H AMD) retardation factor score, these patients were categorized as low (score <8) or high (score>or=8) levels of retardation at baseline.HAMD retardation factor score (total of items 1:depressed mood, 7:work and activity, 8:retardation, 13:somatic general symptoms and 14:urogenital symptoms) andHopkins Symptom Checklist 58 (HSCL-58) energy-related items (including item 14:feeling low in energy or slowed down, 32:feeling no interest in things, 55:absorption in the difficulty) was used as the primary measure of the improvement of energy.RESULTS: 6 weeks after treatment, HAMD total scores, retardation factor score and SCL-58 energe-related items scores decreased more significantly in fluoxetine group than that in amitriptylined group (P <0.05) after 1-2 weeks treatment.No significant difference of efficacy was found between high and low level of retardation in fluoxetine group, but the efficacy of high levels of retardation was less than that of low levels (P <0.05) in amitriptyline group.Compared to amitriptyline-treated subgroup, the efficacy level of fluoxetine-treated high levels of retardation subgroup was higher (P <0.05). CONCLUSION: Fluoxetine can significantly improve the depression-related disturbances in energy, and it is more suitable for the patients with the higher levels of HAMD retardation factor score.

Key words: clinical trial, fluoxetine, amitriptyline, depression, changes in energy

中图分类号: